Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AAK1 | Q2M2I8 | 9/20 | 0.40 |
| ▸ | UHRF1 | Q96T88 | 2/20 | 0.38 |
| ▸ | CCR1 | P32246 | 1/20 | 0.38 |
| ▸ | CCR5 | P51681 | 1/20 | 0.38 |
| ▸ | CCR8 | P51685 | 1/20 | 0.38 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.36 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.36 |
| ▸ | CD274 | Q9NZQ7 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | BRD4 | O60885 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | CLK4 | Q9HAZ1 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | KMO | O15229 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL161508 | 0.83 | — | — | |
| SCHEMBL30849517 | 0.80 | — | — | |
| SCHEMBL8187659 | 0.80 | KDM4E (0.56) | CCR1CCR5CCR8CYP1A2HSD17B10 | |
| SCHEMBL14970164 | 0.80 | PIM1 (0.46) | AAK1CCR1CCR5CCR8CYP1A2 | |
| SCHEMBL29528045 | 0.80 | KDM4E (0.56) | CCR1CCR5CCR8CYP1A2HSD17B10 | |
| SCHEMBL18850043 | 0.78 | FAAH (0.43) | AAK1UHRF1CYP1A2CYP2C19HSD17B10 | |
| SCHEMBL2129077 | 0.78 | ASIC3 (0.59) | CYP1A2CYP2C19ALDH1A1KMO | |
| SCHEMBL30412356 | 0.78 | ASIC3 (0.59) | CYP1A2CYP2C19ALDH1A1KMO | |
| SCHEMBL29031089 | 0.78 | UHRF1 (0.39) | UHRF1CYP1A1CYP1B1CD274CYP1A2 | |
| SCHEMBL14970049 | 0.77 | ABL1 (0.44) | UHRF1CYP1A2CYP2D6CYP2C19HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10454042-B2 | Organic electroluminescence device | UDC IRELAND LIMITED (IE) | 2019-10-22 | — | — | US | disclosed |
| US-20160079545-A1 | Organic Electroluminescence Device | UDC Ireland (IE) | 2016-03-17 | — | — | US | disclosed |
| US-9287515-B2 | Compositions comprising organic and organometallic compounds, and their applications in organic electroluminescence, light emission, display, and illumination devices | UDC Ireland (IE) | 2016-03-15 | — | — | US | disclosed |
| EP-1956022-B1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT | NIPPON STEEL CHEMICAL CO (JP) | 2012-07-25 | — | — | EP | disclosed |
| US-20120153272-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20120153272-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE | FUJIFILM CORPORATION (JP) | 2012-06-21 | — | — | US | disclosed |
| US-20120091445-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT EMITTING DIODE | CHEIL INDUSTRIES, INC. (KR) | 2012-04-19 | — | — | US | disclosed |
| US-20120091445-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT EMITTING DIODE | CHEIL INDUSTRIES, INC. (KR) | 2012-04-19 | — | — | US | disclosed |
| US-7993760-B2 | Compound for use in organic electroluminescent device and organic electroluminescent device | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2011-08-09 | — | — | US | disclosed |
| US-7993760-B2 | Compound for use in organic electroluminescent device and organic electroluminescent device | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2011-08-09 | — | — | US | disclosed |
| US-20090302742-A1 | Compound for Use in Organic Electroluminescent Device and Organic Electroluminescent Device | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2009-12-10 | — | — | US | disclosed |
| EP-1956022-A1 | COMPOUND FOR ORGANIC ELECTROLUMINESCENT ELEMENT AND ORGANIC ELECTROLUMINESCENT ELEMENT | Nippon Steel Chemical Co., Ltd. (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-6187928-B1 | TREATING FUNGAL DISEASES | THE ROCKEFELLER UNIVERSITY | 2001-02-13 | — | — | US | disclosed |
| US-6087510-A | Method of use of imidazolium cations | THE ROCKEFELLER UNIVERSITY (US) | 2000-07-11 | — | — | US | disclosed |
| US-5969150-A | FLUORESCENT COMPOUNDS FOR MEDICAL DIAGNOSIS, DRUGS AND LABELS OR FUNGICIDES AND VIRICIDES | THE ROCKEFELLER UNIVERSITY (US) | 1999-10-19 | — | — | US | disclosed |
| US-5874587-A | FLUORESCENCE | THE ROCKEFELLER UNIVERSITY (US) | 1999-02-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090302742-A1 | Compound for Use in Organic Electroluminescent Device and Organic Electroluminescent Device | LAGE3, ICMT, PPOX | AAK1 2232/4885UHRF1 4484/4885CCR1 3138/4885 |
| US-20120091445-A1 | COMPOUND FOR ORGANIC OPTOELECTRONIC DEVICE, ORGANIC LIGHT EMITTING DIODE INCLUDING THE SAME, AND DISPLAY DEVICE INCLUDING THE ORGANIC LIGHT EMITTING DIODE | OR51E2, AOX1, OR10J3 | AAK1 2793/4885UHRF1 3552/4885CCR1 1720/4885 |
| US-10454042-B2 | Organic electroluminescence device | EML4, ELOC, ORC3 | AAK1 2819/4885UHRF1 1049/4885CCR1 3292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.